|
May 15
|
MIMEDX to Participate in Upcoming Investor Conferences
|
|
May 2
|
MiMedx Group, Inc. (NASDAQ:MDXG) Q1 2024 Earnings Call Transcript
|
|
May 1
|
Q1 2024 MiMedx Group Inc Earnings Call
|
|
May 1
|
MDXG: MACs Give Credit for Efficacy
|
|
May 1
|
MiMedx Group Inc (MDXG) Q1 2024 Earnings Call Transcript Highlights: Strong Financial ...
|
|
Apr 30
|
MIMEDX Announces First Quarter 2024 Operating and Financial Results
|
|
Apr 16
|
MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30
|
|
Apr 11
|
MDXG: Legal Avenues
|
|
Mar 27
|
MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA
|
|
Mar 21
|
Investing in MiMedx Group (NASDAQ:MDXG) a year ago would have delivered you a 138% gain
|
|
Mar 20
|
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing
|
|
Mar 13
|
MIMEDX Introduces E-Commerce and Account Management Platform
|
|
Mar 4
|
MIMEDX Announces Appointment of Two New Independent Directors
|
|
Feb 12
|
MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28
|
|
Jan 15
|
Owning 49% shares,institutional owners seem interested in MiMedx Group, Inc. (NASDAQ:MDXG),
|
|
Dec 29
|
MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook
|
|
Dec 28
|
MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock
|
|
Aug 8
|
Institutional owners may ignore MiMedx Group, Inc.'s (NASDAQ:MDXG) recent US$68m market cap decline as longer-term profits stay in the green
|
|
Jun 22
|
MDXG: KOA Program Discontinued
|
|
Jun 20
|
MIMEDX Announces Strategic Realignment: Increases Focus on Wound & Surgical Business, Expected to Significantly Improve Profitability
|